Progression of pulmonary veno‐occlusive disease without pulmonary hypertension [PDF]
Pulmonary Circulation, 2022 Pulmonary veno‐occlusive disease (PVOD) is a progressively fatal disease with no definitive treatment options. PVOD can be a result of genetic mutation but can also be due secondary to exposure to solvents or chemotherapeutic agents.
Sarah Beshay +3 more
doaj +4 more sources
Pulmonary veno‐occlusive disease with vanished pulmonary consolidation [PDF]
Respirology Case Reports, 2023 Key message Pulmonary veno‐occlusive disease (PVOD) is an extremely rare cause of pulmonary hypertension. Previously reported computed tomography (CT) findings of PVOD included centrilobular ground‐glass opacities, a mosaic pattern, and septal lines ...
Kei Yamasaki +6 more
doaj +2 more sources
Genetic cause of pulmonary veno-occlusive disease [PDF]
Lung India, 2022 Pulmonary veno-occlusive disease (PVOD) is an important cause of pulmonary arterial hypertension (PAH) and is classified under idiopathic cause of PAH. Over a period of time, PVOD has been studied in detail in the western countries and various diagnostic
Kaustubh Mohite, Anil Kumar Sapare
doaj +2 more sources
Mitomycin induced pulmonary veno-occlusive disease [PDF]
Respiratory Medicine Case Reports, 2021 Pulmonary veno-occlusive disease (PVOD) is a rare but devastating cause of pulmonary hypertension (PH) characterized by preferential remodeling of the pulmonary venules.Mitomycin-C (MMC) is an alkylating agent commonly used in chemotherapy with ...
Afua Kunadu +5 more
doaj +2 more sources
Efficacy and safety of oral pulmonary vasodilators in pulmonary veno‐occlusive disease [PDF]
Pulmonary Circulation, 2022 Pulmonary veno‐occlusive disease (PVOD) or pulmonary capillary hemangiomatosis (PCH) is a rare subtype of pulmonary hypertension with dismal prognosis.
Junichi Nakamura +12 more
doaj +2 more sources
Pulmonary Veno-Occlusive Disease after Autologous Stem Cell Transplantation [PDF]
Case Reports in Oncology, 2023 Pulmonary veno-occlusive disease (PVOD) is an extremely rare condition in oncology practice. Although PVOD is clinically similar to pulmonary arterial hypertension, the conditions differ in terms of pathophysiology, management, and prognosis. This report
Takashi Hamada +14 more
doaj +2 more sources
Pulmonary hypertension secondary to interstitial fibrosis with pulmonary venous lesions masquerading pulmonary veno‐occlusive disease [PDF]
Respirology Case Reports, 2023 We present a 41‐year‐old man with idiopathic interstitial pneumonia and pulmonary hypertension (PH) in the setting of a non‐autoimmune background whose clinical presentation masqueraded pulmonary veno‐occlusive disease (PVOD).
Hiroki Nakayama +13 more
doaj +2 more sources
Long-term sildenafil therapy for pulmonary veno-occlusive disease in association with melphalan therapy for multiple myeloma: A case report [PDF]
SAGE Open Medical Case ReportsPulmonary veno-occlusive disease has a significantly worse prognosis than idiopathic pulmonary arterial hypertension. According to a case series from France, the median survival time from diagnosis to death or lung transplantation was only 1 year, and in
Christian Hesse +3 more
doaj +2 more sources
When you hear hoofbeats, think zebras – pulmonary veno‐occlusive disease: A case report [PDF]
Pulmonary Circulation, 2022 Pulmonary veno‐occlusive disease (PVOD) is a rare disease. It may be idiopathic or associated, in particular, with connective tissue disease, or it may develop after radiation exposure; in heritable forms of PVOD, the inheritance is autosomal recessive ...
Laura Scelsi +9 more
doaj +2 more sources